InsidersTradesSigma
Follow the Ascelia Pharma AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Ascelia Pharma AB has published 9 public disclosures. Market capitalisation: €65.6m. The latest transaction was disclosed on 26 November 2025 (Purchase). Among the most active insiders: Peter Benson. Every trade is free.
9
Insider Decl.
n/a
Thresholds
€4,840
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ascelia Pharma AB Strong Buy (bullish), based on 3 analysts. Average price target: SEK 2.87.
36Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 November 2025
Declarations9 total
24,975 shares0AktieISIN SE0010573113FI:A003U165-1
1,754 shares0AktieISIN SE0010573113FI:A003U157-1
15,000 shares@ €0.32270.0012% mcap100.0% of flowAktieISIN SE0010573113FI:A003S559-1
6,152 shares@ €0.19270.0003% mcap22.1% of flowAktieISIN SE0010573113FI:A003N440-1
21,688 shares@ €0.19270.0011% mcap77.9% of flowWarrantISIN SE0022725438FI:A003N439-1
10,000 shares@ €0.19270.0005% mcap100.0% of flowAktieISIN SE0010573113FI:A003N414-1
100,000 shares@ €0.19270.0049% mcap100.0% of flowAktieISIN SE0010573113FI:A003N410-1
112,500 shares0AktieISIN SE0010573113FI:A001P652-2
539,685 shares0AktieISIN SE0010573113FI:A001P626-2
9 of 9 declarations
关于 Ascelia Pharma AB
Ascelia Pharma AB 是一家生物制药公司，专注于开发治疗健康相关疾病的药物。该公司在斯德哥尔摩证券交易所 (XSTO) 上市。